# FDA Inspection 1165663 - Toby L Simon MD - March 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/toby-l-simon-md/14b56521-dda3-4ccf-a8a5-c17e32d25f7a
Source feed: FDA_Inspections

> FDA Inspection 1165663 for Toby L Simon MD on March 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165663
- Company Name: Toby L Simon MD
- Inspection Date: 2022-03-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1091969 - 2019-05-22](https://www.keypedia.com/records/fda_inspections/toby-l-simon-md/4dd286ad-d434-4a5c-92d0-cc6c11d7bcaf)
- [FDA Inspection 925393 - 2015-04-29](https://www.keypedia.com/records/fda_inspections/toby-l-simon-md/75aac2f1-cf09-4e6f-8d28-ab7abc90bfde)

Company: https://www.keypedia.com/companies/toby-l-simon-md/bfee1c84-7cd1-4b28-bf42-fab9be52dd56

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d